Cornell Heme/Onc

Piperacillin/Tazobactam  Use:- Neutropenic fever

Ipratropium

Valacyclovir (Valtrex), Psaconazole

Bcl-2 inhibitor Use:- CLL with 17p mutation or relapse Adverse effects:- Tumor lysis syndrome- Neutropenia, thrombocytopenia

Hypomethylating agent, Cytidine analog Use:- AML- Myelodysplastic syndromes

Bortezomib Proteosome inhibitor Use:- Relapsed multiple myeloma and mantel cell lymphoma

CD38 inhibitor (overexpressed by multiple myeloma cells)

Lenalidomide Use:- Multiple myeloma- Mantel cell lymphoma- Deletion 5q myelodysplastic syndrome

Hydromorphine hydrochloride

Cefalexin 1st generation cephalosporine

Multi-targeted protein kinase inhibitor Use:- AML positive for FLT3- MDS

Purine nucleotide antimetabolite Use:- ALL- AML- Bridge to hematopoietic stem cell transplant

Ruxolitinib JAK1/2 kinase inhibitor Use:- Myelofibrosis- Polycythemia vera unresponsive to hydroxyurea- Pretreatment of BMT to shrink spleen

Phosphate binding drug Use:- Hyperphosphatemia in patients with CKD

Cytarabine and daunorubicin 7+3 Use- t-AML- AML-MRC (myelodysplasia related changes)

Cyclosporine

Targets CD33 Use:- Older patients with previously untreated AML unfit for chemotherapy

Tyrosine protein kinase inhibitor (VEGF, PDGFR, Raf family kinases) Use:- Renal cell carcinoma- Unresectable HCC- Thyroid cancer- AML (FLT3-ITD+)

Tyrosine kinase inhibitor Use:- Imatinib-resistant CML